Microtablet Manufacturing via Multi-Directional Compression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for forming microtablets from bioactive compounds like proteins, antibodies, and peptides often result in significant loss of bioactivity due to denaturation or disruption of the compound's structure during fabrication processes such as molding, compression, milling, grinding, or encapsulation.

Innovation Solution

The development of an apparatus and method that uses movable members to direct, collect, and compress pharmaceutical powders into microtablets, maintaining the integrity of the bioactive compounds by controlling the density and structure of the compressed mass through multiple directional compressions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If conventional fabrication processes (molding, compression, milling, grinding, or encapsulation) are used to form bioactive compounds into tablets, then the drug can be delivered in solid form, but the bioactivity of the drug is significantly lost due to denaturation or disruption of the protein structure

Engineering Contradiction:
ImproveAbility to form solid tablet shapeVSAvoidBioactivity retention
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention changes the physical parameters of the compression process by using low compression forces and controlled density ranges (0.8-1.2 g/cm³) to avoid denaturation while still forming solid tablets. This parameter optimization allows the protein structure to remain intact during tablet formation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses a dynamic compression approach where a movable member progressively compresses the powder bed in stages rather than applying static high force immediately. This dynamic process allows gradual densification that preserves bioactivity while achieving the desired solid form.

Inventive Principle:
Principle #15Dynamics

2Strength

If high compression forces are applied to increase tablet density, then the tablet structural integrity is improved, but the bioactivity of the protein drug is reduced due to structural disruption

Engineering Contradiction:
ImproveTablet structural integrityVSAvoidBioactivity
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

The invention performs preliminary actions by first forming a green compact with low density and then progressively densifying it through controlled compression stages. This preliminary formation at low stress prevents initial denaturation, and subsequent gentle densification achieves structural integrity without excessive force.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The compression process is divided into periodic stages with rest intervals, allowing the protein structure to adapt to compression stress gradually. This periodic action prevents sudden structural disruption while achieving the desired tablet density and integrity.

Inventive Principle:
Principle #19Periodic action

3Reliability

If the powder is loosely packed to maintain bioactivity, then the bioactivity is preserved, but the tablet density and structural integrity are insufficient for stable delivery

Engineering Contradiction:
ImproveBioactivity retentionVSAvoidTablet density consistency
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The invention employs continuous compression action without interruption to progressively densify the powder bed. This continuous process ensures uniform density distribution throughout the tablet while maintaining bioactivity, eliminating the need for loose packing that would compromise structural integrity.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the formation of microtablets with minimal loss of bioactivity, achieving a high percentage of the drug's original biological activity post-manufacturing, and ensuring consistent pharmacokinetic parameters.

Implementation Method 1

a first moveable member may be moved from a first position to a second position within the cavity to compress, compact or otherwise concentrate or direct the pharmaceutical powder to form a collected mass of powder

Methodology Applied
Scientific EffectCompression: Compression

Implementation Method 2

The compressing or compacting by second movable member can optionally serve to further increase the density of the pharmaceutical powder, i.e. to have a second density greater than the first density. The second direction movement of second movable member can optionally be orthogonal to the first direction movement of first movable member

Methodology Applied
Scientific EffectCompression: Compression

Implementation Method 3

The third movable member may further include a reciprocating member articulating in a third direction such that with each successive reciprocation of movable member, the density of the powder incrementally increases to generate a compacted solid mass at a final density and shape

Methodology Applied
Scientific EffectCompression: Compression

Data Source

PatentEP3890708B1Method and apparatus for manufacturing microtablets
Publication Date: 2025.04.23 INCUBE LABS LLC
  • EP3890708B1 patent drawingFigure 1
  • EP3890708B1 patent drawingFigure 2
  • EP3890708B1 patent drawingFigure 3

AI summary

Embodiments provide methods and apparatus for manufacturing a microtablet from a precursor material such as a pharmaceutical powder. Various embodiments provide a method which includes compressing the powder to form a compressed mass of a selected density and repeatedly compacting the compressed mass to increase the density of the compressed mass and form a microtablet. Related methods and apparatus are provided.